These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

360 related articles for article (PubMed ID: 2461800)

  • 1. Significance of purine salvage in circumventing the action of antimetabolites in rat hepatoma cells.
    Natsumeda Y; Ikegami T; Olah E; Weber G
    Cancer Res; 1989 Jan; 49(1):88-92. PubMed ID: 2461800
    [TBL] [Abstract][Full Text] [Related]  

  • 2. De novo guanylate synthesis in the commitment to replication in hepatoma 3924A cells.
    Natsumeda Y; Ikegami T; Murayama K; Weber G
    Cancer Res; 1988 Feb; 48(3):507-11. PubMed ID: 3121175
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enzymic capacities of purine de Novo and salvage pathways for nucleotide synthesis in normal and neoplastic tissues.
    Natsumeda Y; Prajda N; Donohue JP; Glover JL; Weber G
    Cancer Res; 1984 Jun; 44(6):2475-9. PubMed ID: 6327016
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Salvage capacity of hepatoma 3924A and action of dipyridamole.
    Weber G; Lui MS; Natsumeda Y; Faderan MA
    Adv Enzyme Regul; 1983; 21():53-69. PubMed ID: 6443595
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gout and the regulation of purine biosynthesis.
    Hershfield MS; Seegmiller JE
    Horiz Biochem Biophys; 1976; 2():134-62. PubMed ID: 776767
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Regulation of purine nucleotide biosynthesis in mutant Saccharomyces cerevisiae yeasts with increased sensitivity of the pathway for de novo synthesis to inhibition by exogenous guanine].
    Smolina VS; Andrianova VM; Bekker ML
    Genetika; 1978 Sep; 14(9):1495-1502. PubMed ID: 214373
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Purine metabolism of human glioblastoma in vivo.
    Pillwein K; Chiba P; Knoflach A; Czermak B; Schuchter K; Gersdorf E; Ausserer B; Murr C; Goebl R; Stockhammer G
    Cancer Res; 1990 Mar; 50(5):1576-9. PubMed ID: 2154328
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targets and markers of selective action of tiazofurin.
    Weber G; Natsumeda Y; Pillwein K
    Adv Enzyme Regul; 1985; 24():45-65. PubMed ID: 2424286
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sequential impact of tiazofurin and ribavirin on the enzymic program of the bone marrow.
    Prajda N; Hata Y; Abonyi M; Singhal RL; Weber G
    Cancer Res; 1993 Dec; 53(24):5982-6. PubMed ID: 7903199
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Control of enzymic programs and nucleotide pattern in cancer cells by acivicin and tiazofurin.
    Weber G; Natsumeda Y; Lui MS; Faderan MA; Liepnieks JJ; Elliott WL
    Adv Enzyme Regul; 1984; 22():69-93. PubMed ID: 6206692
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biochemical effect of three different inhibitors of purine/pyrimidine metabolism on differentiation in HL60 cells.
    Ahmed N; Weidemann MJ
    Leuk Res; 1995 Apr; 19(4):263-73. PubMed ID: 7538618
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Insulin regulatory effects on purine- and pyrimidine metabolism in alloxan diabetic rat liver.
    Pillwein K; Reardon MA; Jayaram HN; Natsumeda Y; Elliott WL; Faderan MA; Prajda N; Sperl W; Weber G
    Padiatr Padol; 1988; 23(2):135-44. PubMed ID: 3043317
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Purine metabolism in myeloid precursor cells during maturation. Studies with the HL-60 cell line.
    Lucas DL; Webster HK; Wright DG
    J Clin Invest; 1983 Dec; 72(6):1889-900. PubMed ID: 6139386
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Purine enzymology of human colon carcinomas.
    Natsumeda Y; Lui MS; Emrani J; Faderan MA; Reardon MA; Eble JN; Glover JL; Weber G
    Cancer Res; 1985 Jun; 45(6):2556-9. PubMed ID: 3986794
    [TBL] [Abstract][Full Text] [Related]  

  • 15. De novo synthesis of purine nucleotides in human peripheral blood leukocytes. Excessive activity of the pathway in hypoxanthine-guanine phosphoribosyltransferase deficiency.
    Brosh S; Boer P; Kupfer B; de Vries A; Sperling O
    J Clin Invest; 1976 Aug; 58(2):289-97. PubMed ID: 956368
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biochemically directed therapy of leukemia with tiazofurin, a selective blocker of inosine 5'-phosphate dehydrogenase activity.
    Tricot GJ; Jayaram HN; Lapis E; Natsumeda Y; Nichols CR; Kneebone P; Heerema N; Weber G; Hoffman R
    Cancer Res; 1989 Jul; 49(13):3696-701. PubMed ID: 2567208
    [TBL] [Abstract][Full Text] [Related]  

  • 17. De novo GMP synthesis is required for axon guidance in Drosophila.
    Long H; Cameron S; Yu L; Rao Y
    Genetics; 2006 Mar; 172(3):1633-42. PubMed ID: 16322525
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tiazofurin: molecular and clinical action.
    Weber G; Prajda N; Abonyi M; Look KY; Tricot G
    Anticancer Res; 1996; 16(6A):3313-22. PubMed ID: 9042306
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mechanism of resistance to tiazofurin in hepatoma 3924A.
    Jayaram HN; Pillwein K; Lui MS; Faderan MA; Weber G
    Biochem Pharmacol; 1986 Feb; 35(4):587-93. PubMed ID: 2868729
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Some regulatory and integrative aspects of purine nucleotide biosynthesis and its control: an overview.
    Watts RW
    Adv Enzyme Regul; 1983; 21():33-51. PubMed ID: 6152730
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.